Ultrasound-Mediated Gene and Drug Delivery Using a Microbubble-Liposome Particle System

Theranostic agents present a promising clinical approach for cancer detection and treatment. We herein introduce a microbubble and liposome complex (MB-Lipo) developed for ultrasound (US) imaging and activation. The MB-Lipo particles have a hybrid structure consisting of a MB complexed with multiple Lipos. The MB components are used to generate high echo signals in US imaging, while the Lipos serve as a versatile carrier of therapeutic materials. MB-Lipo allows high contrast US imaging of tumor sites. More importantly, the application of high acoustic pressure bursts MBs, which releases therapeutic Lipos and further enhances their intracellular delivery through sonoporation effect. Both imaging and drug release could thus be achieved by a single US modality, enabling in situ treatment guided by real-time imaging. The MB-Lipo system was applied to specifically deliver anti-cancer drug and genes to tumor cells, which showed enhanced therapeutic effect. We also demonstrate the clinical potential of MB-Lipo by imaging and treating tumor in vivo.

[1]  J. Bartlett,et al.  Validation of activated caspase‐3 antibody staining as a marker of apoptosis in breast cancer , 2012, Histopathology.

[2]  Kishan Dholakia,et al.  Membrane disruption by optically controlled microbubble cavitation , 2005 .

[3]  Y. Barenholz Doxil®--the first FDA-approved nano-drug: lessons learned. , 2012, Journal of controlled release : official journal of the Controlled Release Society.

[4]  Michiel Postema,et al.  Sonoporation: mechanistic insights and ongoing challenges for gene transfer. , 2013, Gene.

[5]  Paul A Dayton,et al.  The magnitude of radiation force on ultrasound contrast agents. , 2002, The Journal of the Acoustical Society of America.

[6]  A. S. Moses,et al.  Imaging and drug delivery using theranostic nanoparticles. , 2010, Advanced drug delivery reviews.

[7]  M. A. Arangoa,et al.  Increased receptor-mediated gene delivery to the liver by protamine-enhanced-asialofetuin-lipoplexes , 2003, Gene Therapy.

[8]  R. Shiu,et al.  Stimulation of c-myc oncogene expression associated with estrogen-induced proliferation of human breast cancer cells. , 1987, Cancer research.

[9]  Chih-Kuang Yeh,et al.  Paclitaxel-liposome-microbubble complexes as ultrasound-triggered therapeutic drug delivery carriers. , 2013, Journal of controlled release : official journal of the Controlled Release Society.

[10]  H. Shmeeda,et al.  Pharmacological basis of pegylated liposomal doxorubicin: impact on cancer therapy. , 2012, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[11]  Xiaoyang Xu,et al.  Cancer nanotechnology: the impact of passive and active targeting in the era of modern cancer biology. , 2014, Advanced drug delivery reviews.

[12]  G. Salvesen,et al.  Biochemical Characteristics of Caspases-3, -6, -7, and -8* , 1997, The Journal of Biological Chemistry.

[13]  Keon Wook Kang,et al.  The radio-sensitizing effect of xanthohumol is mediated by STAT3 and EGFR suppression in doxorubicin-resistant MCF-7 human breast cancer cells. , 2013, Biochimica et biophysica acta.

[14]  Soodabeh Davaran,et al.  Liposome: classification, preparation, and applications , 2013, Nanoscale Research Letters.

[15]  Hairong Zheng,et al.  Acoustically-active microbubbles conjugated to liposomes: characterization of a proposed drug delivery vehicle. , 2007, Journal of controlled release : official journal of the Controlled Release Society.

[16]  C. Eaves,et al.  Targeting YB-1 in HER-2 overexpressing breast cancer cells induces apoptosis via the mTOR/STAT3 pathway and suppresses tumor growth in mice. , 2008, Cancer research.

[17]  Ralf Seip,et al.  Ultrasound-triggered release of materials entrapped in microbubble-liposome constructs: a tool for targeted drug delivery. , 2010, Journal of controlled release : official journal of the Controlled Release Society.

[18]  Stephen Meairs,et al.  Self-assembled liposome-loaded microbubbles: The missing link for safe and efficient ultrasound triggered drug-delivery. , 2011, Journal of controlled release : official journal of the Controlled Release Society.

[19]  M. Swihart,et al.  Nanotoxicity assessment of quantum dots: from cellular to primate studies. , 2013, Chemical Society reviews.

[20]  Hak Soo Choi,et al.  Nanoparticles for Biomedical Imaging: Fundamentals of Clinical Translation , 2010, Molecular imaging.

[21]  K. Loeb,et al.  Ultrasound-targeted microbubble destruction-mediated gene delivery into canine livers. , 2013, Molecular Therapy.

[22]  Mark Borden,et al.  Ultrasound microbubble contrast agents: fundamentals and application to gene and drug delivery. , 2007, Annual review of biomedical engineering.

[23]  S. Wrenn,et al.  Acoustically active liposome-nanobubble complexes for enhanced ultrasonic imaging and ultrasound-triggered drug delivery. , 2014, Wiley interdisciplinary reviews. Nanomedicine and nanobiotechnology.

[24]  Y. Barenholz,et al.  Transmembrane ammonium sulfate gradients in liposomes produce efficient and stable entrapment of amphipathic weak bases. , 1993, Biochimica et biophysica acta.

[25]  E. Grulke,et al.  Metal-based nanoparticle interactions with the nervous system: the challenge of brain entry and the risk of retention in the organism. , 2013, Wiley interdisciplinary reviews. Nanomedicine and nanobiotechnology.

[26]  Jianghong Rao,et al.  Development of novel tumor-targeted theranostic nanoparticles activated by membrane-type matrix metalloproteinases for combined cancer magnetic resonance imaging and therapy. , 2014, Small.

[27]  R. Murthy,et al.  Antibody derivatization and conjugation strategies: application in preparation of stealth immunoliposome to target chemotherapeutics to tumor. , 2011, Journal of controlled release : official journal of the Controlled Release Society.

[28]  A. Look,et al.  The requirement for cyclin D function in tumor maintenance. , 2012, Cancer cell.

[29]  N. Hirashima,et al.  Synergistic effect of a biosurfactant and protamine on gene transfection efficiency. , 2013, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[30]  Xiaodong Zhou,et al.  Role of Sonography for Implantation and Sequential Evaluation of a VX2 Rabbit Liver Tumor Model , 2010, Journal of ultrasound in medicine : official journal of the American Institute of Ultrasound in Medicine.

[31]  Theresa M Reineke,et al.  Theranostics: combining imaging and therapy. , 2011, Bioconjugate chemistry.

[32]  Mark A. Borden,et al.  Advances in Ultrasound Mediated Gene Therapy Using Microbubble Contrast Agents , 2012, Theranostics.

[33]  Dean Ho,et al.  Cancer Nanomedicine: From Drug Delivery to Imaging , 2013, Science Translational Medicine.

[34]  H. Ninomiya The Vascular Bed in the Rabbit Ear: Microangiography and Scanning Electron Microscopy of Vascular Corrosion Casts , 2000, Anatomia, histologia, embryologia.

[35]  Yun Zhou,et al.  The size of sonoporation pores on the cell membrane , 2008, 2008 IEEE Ultrasonics Symposium.

[36]  Kostas Kostarelos,et al.  Liposomes: from a clinically established drug delivery system to a nanoparticle platform for theranostic nanomedicine. , 2011, Accounts of chemical research.

[37]  Matthew J Hasik,et al.  Evaluation of synthetic phospholipid ultrasound contrast agents. , 2002, Ultrasonics.

[38]  R. Jain,et al.  Challenges and key considerations of the enhanced permeability and retention effect for nanomedicine drug delivery in oncology. , 2013, Cancer research.

[39]  Cheri X Deng,et al.  Ultrasound-induced cell membrane porosity. , 2004, Ultrasound in medicine & biology.

[40]  Samir Mitragotri,et al.  Healing sound: the use of ultrasound in drug delivery and other therapeutic applications , 2005, Nature Reviews Drug Discovery.

[41]  S. Choi,et al.  Comparison between transauricular and transfemoral arterial access for hepatic artery angiography in a rabbit model. , 2011, Journal of vascular and interventional radiology : JVIR.